Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1997 | 1 |
1999 | 1 |
2008 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 5BAuthor
Page 1
Laser In Situ keratomileusis (LASIK) for the treatment of low moderate, and high myopia.
Trans Am Ophthalmol Soc. 1997;95:285-96; discussion 296-306.
Trans Am Ophthalmol Soc. 1997.
PMID: 9440176
Free PMC article.
Clinical Trial.
At 1 month, 50% were 20/25 or better and 90% were 20/40 or better. The 1 month mean spherical equivalent was -0.26 +/- 0.65 D with 89% between +/- 1.00 D of emmetropia. ...At 1 month, 35% were 20/25 or better and 71% were 20/40 or better. The 1 month m …
At 1 month, 50% were 20/25 or better and 90% were 20/40 or better. The 1 month mean spherical equivalent was -0.26 +/- 0.65 D …
T-2 toxin-induced apoptosis involving Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 signaling pathways in human chondrocytes.
Chen JH, Cao JL, Chu YL, Wang ZL, Yang ZT, Wang HL.
Chen JH, et al.
J Zhejiang Univ Sci B. 2008 Jun;9(6):455-63. doi: 10.1631/jzus.B0820013.
J Zhejiang Univ Sci B. 2008.
PMID: 18543398
Free PMC article.
OBJECTIVE: To investigate the effects of T-2 toxin on expressions of Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 on human chondrocytes. METHODS: Human chondrocytes were treated with T-2 toxin (1-20 ng/ml) for 5 d. Fas, p53 and other apoptosis-related proteins such as Bax, B …
OBJECTIVE: To investigate the effects of T-2 toxin on expressions of Fas, p53, Bcl-xL, Bcl-2, Bax and caspase-3 on human chondrocytes. METHO …
Item in Clipboard
Six-month results of hyperopic and astigmatic LASIK in eyes with primary and secondary hyperopia.
Lindstrom RL, Hardten DR, Houtman DM, Witte B, Preschel N, Chu YR, Samuelson TW, Linebarger EJ.
Lindstrom RL, et al.
Trans Am Ophthalmol Soc. 1999;97:241-55; discussion 255-60.
Trans Am Ophthalmol Soc. 1999.
PMID: 10703127
Free PMC article.
At 6 months, 79% of primary hyperopes had uncorrected visual acuity (UCVA) of 20/40 or better; 63% were within +/- 1 D of emmetropia. One primary hyperope lost 2 lines of best spectacle-corrected vision (BCVA) at 1 month. ...In those with secondary hyperopia, mean manifest …
At 6 months, 79% of primary hyperopes had uncorrected visual acuity (UCVA) of 20/40 or better; 63% were within +/- 1 D of emmetropia. …
Item in Clipboard
Cite
Cite